# RTI International

> RTI International is a VC fund backing Health Care and Manufacturing. See 14 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Raleigh, United States
- Total investments: 14
- Last investment: May 2026
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/rti-international/
- X (Twitter): http://twitter.com/RTI_Intl
- Website: http://www.rti.org
- Facebook: http://www.facebook.com/rti.international

RTI International is a VC fund in Raleigh focused on Health Care and Manufacturing. RTI is an independent, nonprofit institute that provides research, development, and technical services to government and commercial clients.

## Contacts

5 contacts available for RTI International. Shizune tracks 22 team members at RTI International. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/research-triangle?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 29% |
| Manufacturing | 4 | 29% |
| Electronics | 3 | 21% |
| Information Technology | 3 | 21% |
| Medical | 2 | 14% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 21% |
| Series B | 2 | 14% |
| Private Equity | 2 | 14% |
| Corporate Round | 2 | 14% |
| Seed | 1 | 7% |

9 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Aaron S. Williams | Vice President | 0 | https://shizune.co/investors/profile/aaron-s-williams |
| Allen W. Mangel | Executive Vice President, RTI Health Solutions | 0 | https://shizune.co/investors/profile/allen-w-mangel |
| Cathy Sump | Business Development Operations | 0 | https://shizune.co/investors/profile/cathy-sump |
| Don Bailey | Chair, Fellow Program, and Distinguished Fellow, Early Childhood Development | 0 | https://shizune.co/investors/profile/don-bailey |
| E. Wayne Holden | President and Chief Executive Officer | 0 | https://shizune.co/investors/profile/e-wayne-holden |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Navidence | Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data. |  | Corporate Round | May 05, 2026 |  |
| BEKHealth | BEKHealth offers R&D platform solutions that will increase the efficiency and performance of clinical research operations. | $4M |  | Feb 13, 2025 |  |
| BEKHealth | BEKHealth offers R&D platform solutions that will increase the efficiency and performance of clinical research operations. |  | Corporate Round | Jan 13, 2025 |  |
| b.well Connected Health | b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for consumer engagement, holistic health management, and cost containment. It specializes and supports health plans, health systems, employers and pharmaceutical companies.The company was founded in 2015 and headquartered in Baltimore,Maryland. |  | Private Equity | Jan 13, 2025 |  |
| PierianDx | PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by healthsystems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report. | $30M | Venture - Series Unknown | Nov 02, 2021 |  |
| SWIR Vision Systems | SWIR Vision Systems is in the infrared imaging (IR) business. We have now commercialized the worlds highest resolution IR sensors and cameras globally into the industrial automation and machine vision markets. Our Acuros brand quantum-dot semiconductor technology delivers the highest clarity IR images at the lowest cost. The technology is builtupon low cost CMOS wafers, so is scalable for use as 3D depth sensors for AR/VR based consumer electronics and autonomous vehicle sensing applications. | $5M | Series A | Oct 19, 2021 |  |
| PierianDx | PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by healthsystems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report. | $27M | Series B | Oct 28, 2019 |  |
| SPH Analytics | SPH Analytics provides best-in-class solutions and transformative technologies for provider, payer, and health networks. |  | Seed | Jan 31, 2019 |  |
| Clinical Ink | Clinical Ink, Inc. provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol-specific eSource documents, as well as captures the data required by the protocol. The company also provides an electronicsource record (ESR) for clinical trials that provides cleaner data. In addition, it offers hosting services. Clinical Ink was founded in 2006 and is based in Winston-Salem, North Carolina. | $5.3M | Private Equity | May 14, 2018 |  |
| Nextreme Thermal Solutions | Nextreme designs and manufactures micro-scale thermal and power management products for the semiconductor, photonics, consumer, automotive and defense/aerospace industries. The company has embedded cooling and power generation capabilities into the widely accepted copper pillar bumping process used in high-volume electronic packaging.Nextreme’s breakthrough addresses the most challenging thermal and power management constraints in electronics today, and delivers the only fully-scalable technology solution by leveraging the existing, high-volume flip chip manufacturing infrastructure. By minimizing the need for manufacturing changes and focusing on developing a seamless design-in solution, Nextreme is changing the future of thermal and power management for the entire electronics industry. | $21.4M | Series B | Aug 06, 2008 |  |

10 of 14 investments shown.

## Co-investors
- [Intersouth Partners](https://shizune.co/investors/profile/intersouth-partners) — VC Fund, 3 deals together
- [180 Degree Capital](https://shizune.co/investors/profile/180-degree-capital) — VC Fund, 2 deals together
- [Alliance Technology Ventures](https://shizune.co/investors/profile/alliance-technology-ventures) — VC Fund, 2 deals together
- [ATW Partners](https://shizune.co/investors/profile/atw-partners) — VC Fund, 2 deals together
- [Grotech Ventures](https://shizune.co/investors/profile/grotech-ventures) — VC Fund, 2 deals together
- [Health Catalyst Capital](https://shizune.co/investors/profile/health-catalyst-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does RTI International invest in?

RTI International invests primarily in Health Care, Manufacturing and Electronics startups, most often at Series A and Series B stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact RTI International?

Public channels for RTI International include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at RTI International?

The team at RTI International includes Aaron S. Williams (Vice President), Allen W. Mangel (Executive Vice President, RTI Health Solutions) and Cathy Sump (Business Development Operations), among 22 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co